TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,428,138 | +99.8% | 1,135,092 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $6,719,745 | +48.2% | 1,135,092 | +6.4% | 0.00% | +100.0% |
| Q2 2022 | $4,533,046 | -53.1% | 1,066,599 | +5.0% | 0.00% | -50.0% |
| Q1 2022 | $9,656,663 | -50.3% | 1,015,422 | -0.7% | 0.00% | -50.0% |
| Q4 2021 | $19,436,000 | -29.2% | 1,022,922 | +24.0% | 0.00% | -33.3% |
| Q3 2021 | $27,450,000 | -36.7% | 824,824 | -26.3% | 0.01% | -33.3% |
| Q2 2021 | $43,398,000 | -16.0% | 1,118,783 | +4.4% | 0.01% | -25.0% |
| Q1 2021 | $51,663,000 | -22.1% | 1,071,846 | -16.0% | 0.01% | -20.0% |
| Q4 2020 | $66,351,000 | +96.7% | 1,275,493 | +1.2% | 0.02% | +66.7% |
| Q3 2020 | $33,729,000 | +8548.5% | 1,260,410 | +6202.0% | 0.01% | – |
| Q2 2020 | $390,000 | -51.5% | 20,000 | -80.0% | 0.00% | – |
| Q1 2019 | $804,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |